Complexes were evaluated on LNCaP xenografts. High and stable PSMA-dependent tumor uptake (11.2% ID/g at 4 h p.i.). High kidney uptake 28.9% ID/g. Low non-target organs uptake (<1% ID/g at 4 h p.i.) High target-to-non target ratiosClinical translation: No. This evidence concerns the gene FOLH1 and neoplasm.